Navigation Links
Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

he muscle or injected it intravenously in Pompe disease mice.

Six weeks after muscular injection with the virus containing the muscle-restricted gene, mice exhibited high levels of the enzyme and reduced glycogen content in the injected muscle. The mice also had a reduced immune response to the new enzyme, compared to those in which gene expression was not limited to muscle, they found.

Moreover, intravenous administration of the muscle-targeted gene reduced the glycogen content of heart and skeletal muscle and corrected individual muscle fibers. The effect persisted for 24 weeks post-injection, the team reported.

A second gene therapy strategy, in which the enzyme involved in Pompe disease is inserted into the liver, is also under investigation at Duke, said Koeberl. In the January 2005 issue of Molecular Therapy, the researchers reported that the liver-targeted method also corrected symptoms of Pompe disease in mice.

"The muscle-targeted gene therapy method could circumvent the complications of neutralizing antibodies against introduced enzyme, which currently present obstacles to enzyme replacement therapy and liver-targeted gene therapy in Pompe disease," Koeberl said.

Clinical trials of either the muscle- or liver-targeted gene therapies will likely take several years to launch, Koeberl said.

Collaborators on the gene therapy studies include Baodong Sun, Haoyue Zhang, Luis Franco, Andrew Bird, Ayn Schneider, Sarah Young, Y.T. Chen, and Andy Amalfitano, all of Duke Medical Center, and Talmage Brown, of North Carolina State University College of Veterinary Medicine.


'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. New therapy for HIV/AIDS eliminates needles and excessive toxicity
8. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
9. Gene therapy for Parkinsons disease moves forward in animals
10. Pulsating ultrasound enhances gene therapy for tumors
11. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
Post Your Comments:
(Date:8/21/2014)... A study recently published in the journal ... shows a new role for the protein adenomatous polyposis ... cause of cancer-related deaths in the U.S. , Lead ... Molecular Biosciences and co-leader of the Cancer Biology program ... part of her career trying to understand the various ...
(Date:8/21/2014)... pancreatitis involves the pancreas digesting itself resulting in severe ... the UK around 20,000 patients are diagnosed with the ... cure and treatment is restricted to intravenous fluid and ... Faculty of Life Sciences, who led the research, said ... from gall stones and excessive alcohol intake combined with ...
(Date:8/20/2014)... , Aug. 20, 2014 /CNW/ -  Issue ... and can quickly become life threatening for some children.    ... as 1.2 million Canadians have food allergies and this number ... cent of children are estimated to have food allergies.  ... mild skin irritations and hives to breathing difficulties and loss ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Insulin offers new hope for the treatment of acute pancreatitis 2Information Update - Allergens and food safety at school - What's in your child's lunch? 2Information Update - Allergens and food safety at school - What's in your child's lunch? 3
... Network(R) Video Reports , , ... , April 27 The U.S. Supreme Court has denied the ... Richard I. Fine who has never been charged with ... in L.A. County Central Men,s jail for over a year.  Fine attempted to ...
... 2010 Dominio Amigo S.A.S , a .CO,accredited domain name registrar, ... , , ... , CEO, Dominio Amigo S.A.S , commented, "Domainmonster was a,simple choice for ... gTLD launches, securing the very best Internet real estate,for their customers." "With a ...
... NEW BERN, N.C. , April 27 A hurricane ... your business, information, because you really haven,t thought about it until now. ... Atlantic region, now,s the time to update your document storage plans so ... , , ...
Cached Biology News:U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 2U.S. Supreme Court Allows 'Coercive Confinement' to Continue in Attorney's Civil Contempt Case 3Dominio Amigo Announce Domainmonster as .CO Technical Partner 2Dominio Amigo Announce Domainmonster as .CO Technical Partner 3Hurricane-Proof Your Information 2
(Date:8/20/2014)... Mass. , Aug. 20, 2014  Decision Resources Group finds ... , Russia , India ... $1.6 billion in 2013, roughly equal to the size of ... however, the BRIC market will experience much faster growth as a ... aging population. Other key findings from Decision Resources Group,s ...
(Date:8/20/2014)... 2014 The 6th Annual Arrowhead ... on October 29-30 in San Francisco, CA. This year’s ... government researchers and clinicians focused on addressing and solving ... In the twelve years since the sequencing of the ... introduced with pharmacogenetic information in the label and molecular ...
(Date:8/20/2014)... Aug. 20, 2014 /PRNewswire-iReach/ -- A case study ... between the school,s bioengineering department and the Intel® ... Intel® Software Academic Program, UCSD,s research focuses on ... human body.  Photo - ... the work of Dr. Todd P. Coleman ...
(Date:8/20/2014)... NJ (PRWEB) August 20, 2014 WriteResult®, ... announced today that it has expanded its myPROpad™ ePRO ... the EQ-5D-5L, one of the most widely used ... measuring general health status. The EQ-5D is used during ... generate a measure that can be used to demonstrate ...
Breaking Biology Technology:BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 36th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2Intel and University of San Diego Bioengineering Department Release Case Study on Health Sciences Research 2EQ-5D™ Assessment Now Available for iPad 2
... AUCKLAND, New Zealand, Jan. 6 MicroDose Technologies, ... have entered into a collaboration to investigate the ... generation electronic dry powder inhaler (DPI). Under ... the development of prototypes based upon MicroDose,s inhaler ...
... leader in providing automated, molecular testing solutions, announced today ... to present at the JPMorgan Healthcare Conference, which will ... Francis Hotel in San Francisco, CA. At this conference, ... of the Company at 11:00am on Tuesday, January 13, ...
... in drug-eluting stent technologyNATICK, Mass., Jan. 6 ... today announced that it has acquired Labcoat Limited, ... located in Galway, Ireland. Terms of the ... technology for coating drug-eluting stents that uses precisely ...
Cached Biology Technology:MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3Boston Scientific Acquires Labcoat Limited 2Boston Scientific Acquires Labcoat Limited 3Boston Scientific Acquires Labcoat Limited 4
...
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
... OrientExpress™ System Modules ... synthesis and directional cloning ... T7 expression vectors ... configuring OrientExpress™ Cloning Systems, ...
...
Biology Products: